What: A Multicenter, Double Blind, Randomized, Placebo Controlled Study Evaluating Two Doses of Subcutaneous Pulsatile GnRH Administered via OmniPod Pump for Ovulation Induction in Females with Primary Amenorrhea with Hypogonadotropic Hypogonadism (1 in 3 subject will receive placebo)

Who: Females 18 – 40 years old

Duration: 2 months

  • (Amenorrhea is a lack of a menstrual cycle)